BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 37376531)

  • 1. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
    Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
    Viruses; 2023 May; 15(6):. PubMed ID: 37376531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
    Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
    World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and gut immunomodulation.
    Roy K; Agarwal S; Banerjee R; Paul MK; Purbey PK
    World J Gastroenterol; 2021 Dec; 27(46):7925-7942. PubMed ID: 35046621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
    Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
    World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
    Ahlawat S; Asha ; Sharma KK
    Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated diarrhea.
    Megyeri K; Dernovics Á; Al-Luhaibi ZII; Rosztóczy A
    World J Gastroenterol; 2021 Jun; 27(23):3208-3222. PubMed ID: 34163106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.
    Jin S; Lu X; Xu C
    J Int Med Res; 2022 Oct; 50(10):3000605221129543. PubMed ID: 36238995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.
    Cha MH; Regueiro M; Sandhu DS
    World J Gastroenterol; 2020 May; 26(19):2323-2332. PubMed ID: 32476796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19.
    Levy E; Stintzi A; Cohen A; Desjardins Y; Marette A; Spahis S
    Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G99-G112. PubMed ID: 34009033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
    Scaldaferri F; Ianiro G; Privitera G; Lopetuso LR; Vetrone LM; Petito V; Pugliese D; Neri M; Cammarota G; Ringel Y; Costamagna G; Gasbarrini A; Boskoski I; Armuzzi A
    Inflamm Bowel Dis; 2020 Aug; 26(9):1306-1314. PubMed ID: 32720978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
    Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ
    World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.
    Din AU; Mazhar M; Waseem M; Ahmad W; Bibi A; Hassan A; Ali N; Gang W; Qian G; Ullah R; Shah T; Ullah M; Khan I; Nisar MF; Wu J
    Biomed Pharmacother; 2021 Jan; 133():110947. PubMed ID: 33197765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations.
    Perisetti A; Gajendran M; Mann R; Elhanafi S; Goyal H
    Dis Mon; 2020 Sep; 66(9):101064. PubMed ID: 32807535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of SARS-CoV-2 infection for neurogastroenterology.
    Marasco G; Lenti MV; Cremon C; Barbaro MR; Stanghellini V; Di Sabatino A; Barbara G
    Neurogastroenterol Motil; 2021 Mar; 33(3):e14104. PubMed ID: 33591607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal Disease and COVID-19: A Review of Current Evidence.
    Chen F; Dai Z; Huang C; Chen H; Wang X; Li X
    Dig Dis; 2022; 40(4):506-514. PubMed ID: 34510032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 on the Intestinal Microbiome.
    Venegas-Borsellino C; Sankararaman S; Roche K; Burns J; Landis RM
    Curr Nutr Rep; 2021 Dec; 10(4):300-306. PubMed ID: 34813042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Pathophysiological Mechanisms of COVID-19-associated Gastrointestinal Manifestations.
    Aslan AT; Şimşek H
    Euroasian J Hepatogastroenterol; 2021; 11(2):81-86. PubMed ID: 34786361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric COVID-19 and the GUT.
    Gupta R; Beg S; Jain A; Bhatnagar S
    Indian J Med Microbiol; 2020; 38(3 & 4):261-264. PubMed ID: 33154233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.